| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 94 |
| 1 | PREDNISONE | 46 |
| 2 | ADALIMUMAB | 45 |
| 3 | ALBUTEROL SULFATE | 45 |
| 4 | PANTOPRAZOLE | 43 |
| 5 | OCRELIZUMAB | 40 |
| 6 | ASPIRIN | 37 |
| 7 | ASPIRIN 325 MG | 35 |
| 8 | ASPIRIN 81 MG | 35 |
| 9 | METHOTREXATE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GREEN TEA LEAF | 1 | 0.0250 |
| 1 | LULICONAZOLE | 2 | 0.0114 |
| 2 | CIPAGLUCOSIDASE ALFA-ATGA | 1 | 0.0110 |
| 3 | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | 1 | 0.0081 |
| 4 | VYJUVEK | 1 | 0.0076 |
| 5 | NIRAPARIB | 94 | 0.0042 |
| 6 | DIFLUNISAL | 3 | 0.0037 |
| 7 | FAMOTIDINE 20MG | 1 | 0.0027 |
| 8 | EPINASTINE HYDROCHLORIDE | 3 | 0.0026 |
| 9 | ELBASVIR AND GRAZOPREVIR | 9 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 106 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 61 |
| 3 | Loop Diuretic [EPC] | 42 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 37 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 37 |
| 6 | Benzodiazepine [EPC] | 34 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 32 |
| 8 | Vitamin C [EPC] | 32 |
| 9 | Calcium Channel Blocker [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | alpha-Hydroxy Acid [EPC] | 4 | 0.0018 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 3 | Sulfonamide Antibacterial [EPC] | 5 | 0.0013 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 5 | Asparagine-specific Enzyme [EPC] | 12 | 0.0009 |
| 6 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 7 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 25 | 0.0008 |
| 9 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 9 | 0.0006 |